Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-11-19
2008-03-11
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S123000
Reexamination Certificate
active
07342024
ABSTRACT:
Compounds represented by Formula (I): or a pharmaceutically acceptable salt thereof, are phosphodiesterase 4 inhibitors useful in the treatment of asthma and inflammation and useful for the enhancement of cognition
REFERENCES:
patent: 2003/0096829 (2003-05-01), Li et al.
patent: WO 99/07704 (1999-02-01), None
patent: WO 02/094823 (2002-11-01), None
Mainou-Fowler et la., Leukemia and Lymphoma, “Tumour Necrosis Factor gene polymorphisms in Lymphoproliferative disease”, 2000, vol. 38, pp. 547-552.
Aspiotis Renee
Dube Daniel
Dube Laurence
Gallant Michel
Girard Yves
Ayler Sylvia A.
Krovatin William
Merck Frost Canada Ltd.
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
4-Oxo-1-3-substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Oxo-1-3-substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Oxo-1-3-substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3977708